享受國(guó)務(wù)院特殊津貼專家
國(guó)家教育部新世紀(jì)優(yōu)秀人才
山西省委聯(lián)系的高級(jí)專家
山西省勞動(dòng)競(jìng)賽委員會(huì)榮記一等功
山西省“十佳”中青年優(yōu)秀科技工作者
山西省衛(wèi)健委“醫(yī)學(xué)科技卓越專家”
山西省學(xué)術(shù)技術(shù)帶頭人
山西省“三晉英才”
學(xué)術(shù)任職：
中國(guó)病理生理學(xué)會(huì)常務(wù)理事
中國(guó)病理生理學(xué)會(huì)消化專業(yè)委員會(huì)原主任委員
中國(guó)醫(yī)師協(xié)會(huì)胰腺病專業(yè)委員會(huì)慢性胰腺炎專業(yè)委員會(huì)委員
山西省醫(yī)學(xué)會(huì)消化病學(xué)專業(yè)委員會(huì)副主任委員
山西省醫(yī)學(xué)會(huì)全科醫(yī)學(xué)分會(huì)副主任委員
山西省醫(yī)師協(xié)會(huì)肝病醫(yī)師分會(huì)副會(huì)長(zhǎng)
山西省醫(yī)師協(xié)會(huì)肝病醫(yī)師分會(huì)肝癌學(xué)組副主任委員
山西門靜脈高壓聯(lián)盟常務(wù)理事
近五年承擔(dān)科研課題情況：
國(guó)家自然科學(xué)基金面上項(xiàng)目，項(xiàng)目名稱：IGFBPrP1在致肝纖維化形成中對(duì)肝星狀細(xì)胞自噬的調(diào)節(jié)機(jī)制，項(xiàng)目編號(hào)：81670559，項(xiàng)目起止時(shí)間：2017.01-2020.12。
中央引導(dǎo)地方科技發(fā)展資金項(xiàng)目，項(xiàng)目名稱：IGFBPrP1及鐵死亡在非酒精性脂肪性肝病中的作用機(jī)制研究，項(xiàng)目編號(hào)：YDZX20201400001965，項(xiàng)目起止時(shí)間：2020.07-2021.12。
山西省自然科學(xué)基金面上項(xiàng)目，項(xiàng)目名稱：酒精觸發(fā)肝細(xì)胞鐵死亡在酒精性肝病進(jìn)程中的作用機(jī)制研究，項(xiàng)目編號(hào)：202103021224392，項(xiàng)目起止時(shí)間：2022.01-2024.12。
山西省衛(wèi)生健康委員會(huì)“四個(gè)一批”科技興醫(yī)創(chuàng)新計(jì)劃肝損傷與消化道腫瘤防治委級(jí)重點(diǎn)實(shí)驗(yàn)室，項(xiàng)目編號(hào)：晉衛(wèi)科教函[2021]9號(hào)No.2020SYS19，項(xiàng)目起止時(shí)間：2021.01-2023.01。
代表性論著及近五年的代表性論文（限10項(xiàng)以內(nèi)）：
Lina Ji, Qianqian Zhang, Yumeng Cao, Lixin Liu*. A prognostic risk model, tumor immune environment modulation, and drug prediction of ferroptosis and amino acid metabolism-related genes in hepatocellular carcinoma. Human Cell, 2023; 36(3): 1173-1189.
Yuhang Han, Yanqin Wang, Jiaqi Bo, Yanna Guo, Lixin Liu*. ABCC1 is a predictive biomarker for prognosis and therapy in hepatocellular carcinoma. Eur Rev Med Pharmacol Sci, 2023; 27(8): 3597-3611.
Zihe Zhu, Qianqian Zhang, Lixin Liu*, Jun Xu*. Human umbilical cord mesenchymal stem cell’s cultivation and treatment of liver dseases. Current Stem Cell Research & Therapy, 2023; 18(3): 286-298.
Zhihui Hu, Yangyang Kong, Junjie Ren, Tingjuan Huang, Yanqin Wang, Lixin Liu*. Kidney and lung tissue modifications after BDL-induced liver injury in mice are associated with increased expression of IGFBPrP1 and activation of the NF-κB inflammation pathway. International Journal of Clinical and Experimental Pathology, 2020; 13(2): 192-202.
Yangyang Kong, Tingjuan Huang, Haiyan Zhang, Qianqian Zhang, Junjie Ren, Xiaohong Guo, Huiqin Fan, Lixin Liu*. The lncRNA NEAT1/miR-29b/Atg9a axis regulates IGFBPrP1-induced autophagy and activation of mouse hepatic stellate cells. Life Sciences, 237(2019)116902.
Tingjuan Huang, Junjie Ren, Qianqian Zhang, Yangyang Kong, Haiyan Zhang, Xiaohong Guo, Huiqin Fan, Lixin Liu*. IGFBPrP1 accelerates autophagy and activation of hepatic stellate cells via mutual regulation between H19 and PI3K/AKT/mTOR pathway. Biomedicine & Pharmacotherapy, 116(2019)109034.
Junjie Ren, Tingjuan Huang, Qianqian Zhang, Haiyan Zhang, Xiaohong Guo, Huiqin Fan, Renke Li, Lixin Liu*. Insulin-like growth factor binding protein related protein 1 knockdown attenuates hepatic fibrosis via the regulation of MMPs/TIMPs in mice. Hepatobiliary & Pancreatic Diseases International, 2019; 18(1): 38-47.
Yuanfei Li, Yanfeng Xi, Guoqiang Zhu, Junmei Jia, He Huang, Yanyan Liu, Yarong Guo, Lixin Liu*. Downregulated IGFBP7 facilitates liver metastasis by modulating epithelial-mesenchymal transition in colon cancer. Oncology Reports, 2019; 42(5): 1935-1945.
張瑞昕, 劉立新*. 單純血漿置換或聯(lián)合雙重血漿分子吸附系統(tǒng)對(duì)肝衰竭治療價(jià)值的Meta分析. 中華肝臟病雜志, 2022; 30(10): 1107-1114.
10.以第一完成人獲山西省科學(xué)技術(shù)獎(jiǎng)科技進(jìn)步類二等獎(jiǎng)：IGFBPrP1通過(guò)TGFβ1及其相關(guān)信號(hào)通路致肝纖維化作用的臨床意義，證書編號(hào)：2019-J-2-041。
教學(xué)科研
